AbbVie is laying off 59 employees across three California sites, effective Jan. 9, according to a Worker Adjustment and Retraining Notification (WARN) Act notice filed Nov. 13. AbbVie will permanently close the Dublin and Livermore sites after Jan. 9.
All entries for: AbbVie
November 19, 2025
AbbVie
Discontinued Research
North Chicago, IL
50,001+ employees
AbbVie has decided to call it quits with Google’s Calico Life Sciences. The move will involve layoffs affecting around 100 chemists. AbbVie will use the saved money to fund its biologics and cell and RNA therapies.
Disease Area: Oncology
Drug Type: Biologic
November 4, 2025
AbbVie
Negative Outlook
North Chicago, IL
50,001+ employees
AbbVie is also subject to public and legislative pressure with respect to pharmaceutical pricing. In the United States, Executive Order 14297, issued on May 12, 2025, directs the Secretary of Health and Human Services (HHS) to pursue most-favored-nation (MFN) pricing… AbbVie continues to evaluate the potential impact of this executive order, and any new or additional legislation, regulations or executive orders related to pharmaceutical pricing may increase uncertainties and associated risks and could adversely impact AbbVie’s business and results of operations.
November 6, 2023
AbbVie
Negative Outlook
North Chicago, IL
50,001+ employees
“In August 2023, as part of the Inflation Reduction Act (IRA) of 2022, the company’s oncology product Imbruvica sold in the United States (U.S.) was included on the list of products selected for negotiation by the Centers for Medicare & Medicaid Services. The selection resulted in a significant decrease in the estimated future cash flows for the product and represented a triggering event.”
Disease Area: Oncology
Drug Type: Biologic
October 28, 2022
AbbVie
Negative Outlook
North Chicago, IL
50,001+ employees
Andrew Baum of Citigroup asked how ABBV anticipates pricing pressure assuming CMS selects Imbruvica for the Drug Price Negotiation Program and whether they expect it before 2026 due to expected contracting on formulary placement.
Disease Area: Oncology
Drug Type: Biologic